Vorolanib
- Generic Name
- Vorolanib
- Drug Type
- Small Molecule
- Chemical Formula
- C23H26FN5O3
- CAS Number
- 1013920-15-4
- Unique Ingredient Identifier
- YP8G3I74EL
Overview
Vorolanib is under investigation in clinical trial NCT03904719 (CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)).
Background
Vorolanib is under investigation in clinical trial NCT03904719 (CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)).
Indication
与依维莫司联合，用于既往接受过酪氨酸激酶抑制剂治疗失败的晚期肾细胞癌患者。
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath